Tena Rosser

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial”.

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Nature Medicine(2021)10.1038/s41591-020-01193-6

N/A

2.0DataRank · unranked

96 citations

Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi +25 more

Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey

American Journal of Medical Genetics Part A(2021)10.1002/ajmg.a.62490

N/A

0DataRank · unranked

10 citations

Stephanie Reda, Staci Martin, Nour Al Ghriwati, Melissa Baker, Daniel Berg +10 more

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Genetics in Medicine(2022)10.1016/j.gim.2022.05.007

N/A

0DataRank · unranked

278 citations

Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A. Avery, Jaishri O. Blakeley +79 more

Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy

Journal of Pediatric Orthopaedics(2023)10.1097/bpo.0000000000002431

N/A

0DataRank · unranked

9 citations

Krishna V. Suresh, Jaime A. Gómez, John B. Emans, A. Noelle Larson, Patrick J. Cahill +18 more

Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials

Clinical Trials(2023)10.1177/17407745231205577

N/A

0DataRank · unranked

5 citations

Heather L. Thompson, Pamela L. Wolters, Frank D. Buono, Cynthia M. Hingtgen, Tena Rosser +10 more

Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials

Clinical Trials(2023)10.1177/17407745231178839

N/A

0DataRank · unranked

6 citations

Kavita Y. Sarin, Andrea Petersen, Dominique C. Pichard, Pamela L. Wolters, Gregg Erickson +8 more

Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey

Clinical Trials(2023)10.1177/17407745231209224

N/A

0DataRank · unranked

6 citations

Nour Al Ghriwati, Melissa Baker, Staci Martin, Daniel Berg, Gregg Erickson +8 more

Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05024-x

N/A

0DataRank · unranked

2 citations

Pamela L. Wolters, Karin S. Walsh, Nicole J. Ullrich, Tena Rosser, James H. Tonsgard +11 more